Deborah A. Griffin

TEVA

CHIEF ACCOUNTING OFFICER · TEVA PHARMACEUTICAL INDUSTRIES LTD · CIK 0001719115

FILING MIX · LIFETIME38%/62%

BUYS

SELLS

TOTAL VALUE

$108.1K

COMPANIES

ACTIVE SINCE

Feb 2020

HOLDINGS NOW

AVG SELL PX

$10.97

Trades · vs SPY

Loading price series…

Performance · forward returns vs SPY

4 backtested trades · 8 horizons

Forward-return performance of every backtestable P/S trade by Deborah A. Griffin, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.

HORIZON	TRADES	WIN RATE	INSIDER RETURN	SPY RETURN	MEAN EXCESS	MEDIAN EXCESS	T-STAT
7d	4	+75.00%	-12.63%	-7.70%	-4.93%	-10.46%	—
14d	4	+75.00%	-23.03%	-14.73%	-8.30%	-17.13%	—
30d	4	+75.00%	-10.01%	-11.17%	+1.16%	-6.76%	—
60d	4	+75.00%	+4.07%	-2.04%	+6.10%	-4.59%	—
90d	4	+0.00%	+25.14%	+5.76%	+19.38%	+15.06%	—
180d	4	+75.00%	-4.78%	+20.05%	-24.83%	-27.75%	—
1y	4	+75.00%	+10.43%	+34.89%	-24.46%	-30.81%	—
2y	4	+75.00%	-22.39%	+54.69%	-77.08%	-77.63%	—

How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.

Holdings over time

TEVA · 0 shares · as of Mar 17, 2020

Trading cadence · quarterly flow

BUY ● SELL ●

2020

FLOW · 5 buys / 8 sellsCOVERAGE · 1 quarters

Form 4 filings · all activity

COMPANY	TYPE	SHARES	PRICE	VALUE	HELD AFTER	TRADE DATE	FILED
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD	PURCHASE Chief Accounting Officer	944	—	—	944	Mar 17, 2020	Mar 19, 2020 ↗
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD	SALE Chief Accounting Officer	944	—	—	0	Mar 17, 2020	Mar 19, 2020 ↗
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD	SALE Chief Accounting Officer	944	$7.16	$6.8K	0	Mar 17, 2020	Mar 19, 2020 ↗
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD	SALE Chief Accounting Officer	4,807	—	—	14,424	Mar 4, 2020	Mar 5, 2020 ↗
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD	SALE Chief Accounting Officer	4,807	$11.23	$54.0K	0	Mar 4, 2020	Mar 5, 2020 ↗
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD	PURCHASE Chief Accounting Officer	4,807	—	—	4,807	Mar 4, 2020	Mar 5, 2020 ↗
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD	SALE Chief Accounting Officer	1,166	$11.37	$13.3K	0	Mar 3, 2020	Mar 4, 2020 ↗
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD	PURCHASE Chief Accounting Officer	1,166	—	—	1,166	Mar 3, 2020	Mar 4, 2020 ↗
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD	SALE Chief Accounting Officer	1,166	—	—	1,166	Mar 3, 2020	Mar 4, 2020 ↗
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD	SALE Chief Accounting Officer	2,941	—	—	5,882	Mar 2, 2020	Mar 4, 2020 ↗
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD	PURCHASE Chief Accounting Officer	2,941	—	—	2,941	Mar 2, 2020	Mar 4, 2020 ↗
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD	SALE Chief Accounting Officer	2,941	$11.60	$34.1K	0	Mar 2, 2020	Mar 4, 2020 ↗
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD	PURCHASEGRANT Stock grant	21,459	—	—	21,459	Feb 28, 2020	Mar 3, 2020 ↗

Other insiders · TEVA

Loading peer insiders…

About this filer

CIK 0001719115

ROLE

Chief Accounting Officer

PRIMARY

TEVA

COMPANIES

ACTIVE SINCE

Feb 2020

MARKETPEEL · /INSIDER/0001719115DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE

Deborah A. Griffin

The morning brief, before the bell.